Drug Shortage Report for CHLORDIAZEPOXIDE
Report ID | 202741 |
Drug Identification Number | 00522724 |
Brand name | CHLORDIAZEPOXIDE |
Common or Proper name | Chlordiazepoxide |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | CHLORDIAZEPOXIDE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-08-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-08-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-08-23 | English | Compare |
v2 | 2023-08-23 | French | Compare |
Showing 1 to 2 of 2